Otc sleep sits at the center of this dementia and brain health question.
For a broader overview, see our dementia treatment and medications guide.
Otc Sleep Aid: this caregiver-focused guide explains what otc sleep aid means in plain English, the day-to-day implications for families, and when to bring it up with a clinician. If you arrived here looking for a quick orientation on otc sleep aid, the table of contents below points to the section you need; the full guide picks up after it.
Table of contents
- Table of Contents
- What Does New Research Say About OTC Sleep Aids and Cognitive Decline?
- How Diphenhydramine Disrupts Brain Chemistry
- Why the Research Is Complicated — And What Critics Say
- Safer Alternatives for Chronic Sleep Problems
- What About Occasional Use — Is That Safe?
- Talking to a Doctor About Sleep Aid Use
- Where the Science Goes From Here
Diphenhydramine — the active ingredient in Benadryl, ZzzQuil, and Unisom SleepGels — is one of the most widely used over-the-counter sleep aids in America, and a growing body of research suggests that long-term use may significantly raise the risk of cognitive decline and dementia. A landmark 2015 study published in JAMA Internal Medicine tracked over 3,400 older adults for roughly seven years and found that those who took anticholinergic drugs like diphenhydramine for three or more years had a 54% higher risk of developing dementia compared to people who never used them. The finding was not a fluke — a 2021 meta-analysis confirmed the pattern across multiple studies, and a separate UCSF study found that seniors who frequently used sleep medications had a 79% higher chance of developing dementia. Before anyone flushes their medicine cabinet, some important context: no study has proven that diphenhydramine directly causes dementia.
The research is observational, meaning it identifies associations, not definitive cause and effect. Sleep problems themselves can be an early symptom of dementia, which complicates interpretation. Still, the signal is strong enough that the American Geriatrics Society now lists diphenhydramine as inappropriate for older adults on its Beers Criteria. This article breaks down what the research actually shows, how the drug affects your brain, what experts recommend instead, and how to have a practical conversation with your doctor about sleep.
Table of Contents
- What Does New Research Say About OTC Sleep Aids and Cognitive Decline?
- How Diphenhydramine Disrupts Brain Chemistry
- Why the Research Is Complicated — And What Critics Say
- Safer Alternatives for Chronic Sleep Problems
- What About Occasional Use — Is That Safe?
- Talking to a Doctor About Sleep Aid Use
- Where the Science Goes From Here
- Conclusion
- Frequently Asked Questions
What Does New Research Say About OTC Sleep Aids and Cognitive Decline?
The concern centers on a class of drugs called anticholinergics, which block acetylcholine — a neurotransmitter your brain relies on for memory, learning, and general cognitive function. Diphenhydramine is a first-generation antihistamine, and unlike newer options like cetirizine or loratadine, it crosses the blood-brain barrier easily. That is what makes it effective as a sleep aid — it essentially sedates the brain — but it is also what makes researchers nervous about repeated, long-term use. The 2015 Gray et al. study in JAMA Internal Medicine remains the most cited piece of evidence. Researchers followed 3,434 adults aged 65 and older who had no dementia at the start of the study.
They tracked pharmacy records to measure cumulative anticholinergic exposure and found a clear dose-response relationship: the more someone used these drugs over time, the higher their dementia risk climbed. The threshold was not trivial use. One analysis found the association emerging at roughly 50 or more doses per year sustained over eight years; another pegged it at daily use for three or more years. A person who takes diphenhydramine a few times a year for seasonal allergies is in a very different category than someone who pops a ZzzQuil every night for a decade. The UCSF study, published in the Journal of Alzheimer’s Disease, added a troubling demographic wrinkle. Among 3,068 seniors with an average age of 74, white participants who reported “often” or “almost always” using sleep medications faced a 79% higher chance of developing dementia compared to those who rarely or never used them. Interestingly, the same association was not observed among Black participants in that study, raising questions about biological differences, prescribing patterns, or other confounding factors that researchers have not yet untangled.
How Diphenhydramine Disrupts Brain Chemistry
The mechanism researchers find most concerning involves acetylcholine, sometimes called the brain’s “memory chemical.” Every time you take diphenhydramine, it temporarily blocks acetylcholine receptors throughout the brain. For a single dose, this is unlikely to cause lasting harm — the drug wears off, receptors recover, and the brain returns to normal function. The worry is about what happens when those receptors are blocked night after night, year after year. Chronic acetylcholine receptor blockade may trigger the production of beta-amyloid protein, one of the hallmark pathological features of Alzheimer’s disease. Some researchers have also proposed that sustained anticholinergic use could prevent the brain from efficiently clearing beta-amyloid that accumulates naturally. Additional hypotheses involve effects on brain inflammation and blood flow.
However, if you are younger and in good health, the risk profile likely looks very different than it does for a 75-year-old with existing cardiovascular issues. The brain’s resilience varies enormously by age, genetics, and overall health. This is one reason the American Geriatrics Society specifically targets older adults in its warnings rather than issuing a blanket recommendation for all age groups. It is also worth noting that diphenhydramine is not the only anticholinergic drug under scrutiny. Certain bladder medications, antidepressants, and muscle relaxants also carry anticholinergic properties. A person taking diphenhydramine for sleep and oxybutynin for an overactive bladder could be stacking their anticholinergic burden without realizing it — a concept geriatricians call “anticholinergic load.”.
Why the Research Is Complicated — And What Critics Say
Not everyone in the scientific community is convinced these findings should trigger alarm. A Cochrane review — widely considered the gold standard for evaluating medical evidence — rated the overall certainty of evidence linking anticholinergics to dementia as “low.” The reviewers flagged concerns about protopathic bias, which occurs when a drug appears to cause a disease that was actually already developing before the person started taking the medication, and publication bias, where studies finding a link are more likely to be published than those finding none. The reverse causation problem deserves particular attention for anyone reading these headlines. Difficulty sleeping is a known early symptom of several types of dementia, sometimes appearing years before a diagnosis.
This means that at least some of the people in these studies who were taking sleep aids may have already been in the early, undetected stages of cognitive decline. They did not develop dementia because they took diphenhydramine — they took diphenhydramine because they were developing dementia. Disentangling this chicken-and-egg problem is extremely difficult with observational studies. Kenvue, the consumer health company that manufactures Benadryl (formerly a division of Johnson & Johnson), has stated that they “are not aware of any studies that show a causal link between labeled use of diphenhydramine and an increased risk of developing dementia.” The phrase “labeled use” is doing heavy lifting in that statement. Most labels recommend diphenhydramine for short-term, occasional use — not the years-long nightly habit that the concerning research describes.
Safer Alternatives for Chronic Sleep Problems
If you or someone you care for has been relying on diphenhydramine nightly, the most important step is not to simply switch to another pill. Cognitive Behavioral Therapy for Insomnia, known as CBT-I, is recommended as the first-line treatment for chronic insomnia by the American College of Physicians. Unlike medication, CBT-I addresses the underlying behavioral and psychological patterns that perpetuate poor sleep — things like spending too much time in bed awake, irregular schedules, and anxiety about sleep itself. Several randomized trials have shown it to be as effective as medication in the short term and more effective in the long term, without any risk of cognitive side effects.
For people who want an OTC option, melatonin is generally considered safer than diphenhydramine because it does not carry anticholinergic properties. It works differently — supporting the body’s natural circadian rhythm rather than sedating the brain by force. That said, long-term data on melatonin is limited, doses in commercial products vary wildly (some contain far more than what is listed on the label), and it is not a strong sedative. For someone accustomed to the knockout effect of diphenhydramine, melatonin may feel inadequate. The tradeoff is real: melatonin is gentler but also less immediately powerful, and the adjustment period can be frustrating.
What About Occasional Use — Is That Safe?
This is the question most people actually want answered, and the honest answer is that occasional use is generally considered safe by the medical community. The research that raises red flags is specifically about cumulative, long-term exposure — years of regular use, not a dose here and there during a bad week of sleep. One study pegged the threshold at 50 or more doses per year over eight years. Another found the association with daily use sustained for three or more years.
If you take diphenhydramine once a month during allergy season, these findings are unlikely to apply to your situation. The warning applies most acutely to older adults. Beyond the dementia question, diphenhydramine causes a range of immediate side effects in seniors that make it problematic regardless of long-term risk: confusion, excessive sedation, dizziness, urinary retention, and increased fall risk. A 78-year-old who gets up at night to use the bathroom after taking a sedating antihistamine is at real risk of a fall-related hip fracture, which carries its own serious cognitive and mortality consequences. For younger adults with no family history of dementia and no other anticholinergic medications, the occasional use of diphenhydramine is a very different risk calculation — but it is still not recommended as a long-term sleep strategy.
Talking to a Doctor About Sleep Aid Use
Many people never mention their OTC sleep aid use to a physician because they assume it does not count as “real” medication. This is a mistake, particularly for older adults or anyone taking other medications.
A geriatrician or primary care doctor can calculate anticholinergic burden — the total anticholinergic load from all medications combined — and identify whether a patient is unknowingly stacking risk. For example, someone taking diphenhydramine for sleep, an older tricyclic antidepressant, and a bladder medication might have a combined anticholinergic exposure far exceeding what any single prescription would produce. Bring every OTC product you take, including sleep aids, to your next appointment.
Where the Science Goes From Here
The critical missing piece in this body of research is a large, well-designed randomized controlled trial that could establish or rule out causation. Given the ethical difficulties of assigning people to take a potentially harmful drug for years, that study may never happen.
Researchers are instead turning to neuroimaging studies to look for structural brain changes in long-term anticholinergic users and to biomarker studies that could detect shifts in beta-amyloid or tau protein levels. These approaches may never deliver a definitive “guilty” or “not guilty” verdict, but they could sharpen the picture considerably over the next decade. In the meantime, the precautionary principle applies: when safer alternatives exist and the potential downside is dementia, the rational choice is to minimize unnecessary long-term exposure.
Conclusion
The link between diphenhydramine and cognitive decline is not a closed case, but the pattern across multiple large studies is consistent enough to take seriously — particularly for anyone over 65 or anyone using these products nightly for years. A 54% increased dementia risk in long-term users, a 79% higher rate among frequent users in the UCSF study, and confirmation across a systematic meta-analysis all point in the same direction, even as researchers acknowledge the limitations of observational data and the possibility of reverse causation. The practical takeaway is straightforward: treat diphenhydramine as a short-term, occasional tool rather than a nightly habit.
Talk to a doctor about CBT-I for chronic insomnia. Consider melatonin as a gentler OTC option. If you are a caregiver for an older adult, check their medicine cabinet and bring every product — prescription and OTC — to their next medical appointment. The goal is not panic but informed caution, because the most dangerous risk factor is the one nobody bothers to examine.
Frequently Asked Questions
Does taking Benadryl once in a while cause dementia?
The current research does not suggest that occasional, short-term use increases dementia risk. The concerning findings involve cumulative exposure over years — roughly 50 or more doses per year sustained for many years, or daily use for three-plus years.
Is ZzzQuil different from Benadryl when it comes to cognitive risk?
No. ZzzQuil’s active ingredient is diphenhydramine, the same drug in Benadryl. The branding and marketing differ, but the anticholinergic effect on the brain is identical.
Is melatonin a safe long-term alternative?
Melatonin does not carry anticholinergic properties, which makes it a safer option from a cognitive standpoint. However, long-term safety data on melatonin is limited, and commercial products sometimes contain doses that differ from what is listed on the label. It is not as strongly sedating as diphenhydramine.
What is CBT-I, and does it really work for insomnia?
Cognitive Behavioral Therapy for Insomnia is a structured program that targets the thoughts and behaviors that perpetuate sleep problems. Multiple clinical trials have found it as effective as medication in the short term and superior in the long term. It is recommended as first-line treatment by the American College of Physicians.
My parent takes diphenhydramine every night. Should I be worried?
It is worth discussing with their doctor, especially if they are over 65. The American Geriatrics Society lists diphenhydramine as inappropriate for older adults due to side effects including confusion, sedation, and fall risk — separate from the dementia concern. A physician can suggest alternatives and assess total anticholinergic burden from all medications.
Has the manufacturer acknowledged the dementia risk?
Kenvue, which manufactures Benadryl, has stated they are not aware of studies showing a causal link between labeled use of diphenhydramine and increased dementia risk. The label recommends short-term use, which is not the pattern associated with elevated risk in the research.
You Might Also Like
- This Common Sleep Aid Could Be Slowly Damaging Your Brain
- This Common Antibiotic Is Linked to a Dangerous Heart Rhythm Problem
- This Antidepressant Is Being Prescribed Off-Label for Pain — And It Works
Sources used for this Otc Sleep Aid guide
- National Institute on Aging — Caregiving for someone with dementia
- Alzheimer’s Association — Caregiver resources
- Alzheimer’s Foundation of America — Caregiver Resources
This article is informational and not medical advice. See our Editorial Policy for how we research and review content. Last reviewed June 6, 2026.
For more, see NIH MedlinePlus — dementia.
